KUZIK® IN PROPHYLAXIS OF MIGRAINE: A RETROSPECTIVE OBSERVATIONAL STUDY

Stresa Headache 2019

Lo studio e’ stato presentato al congresso stresa headache 2019

Our study clearly demonstrated the benefits, safety, and good tolerability of Kuzik® in the prophylaxis of migraine, with and without aura. This study confirms the data obtained in the previous trial and highlights the positive data obtained with Kuzik® twice daily in patients with chronic disease. The use of this medication should be taken in consideration as a good practice in this setting of patients.